Health & Education · Santa Maria da Feira, Coimbra, and Lisbon
Portuguese adults face vaccine knowledge gaps as hospital study records 18% RSV mortality
Surveys show over 60% of Portuguese adults do not know which vaccines are in the national programme, while a six-year hospital study urges state funding for adult RSV inoculations after documenting high fatality rates.
AI text based on reports by SIC Notícias, Notícias ao Minuto, Diário de Notícias and other publishers. Published . How it is made
For membersThe first 30 seconds for everyone. Synthetic voice (AI).
In brief
While 94.4% of 1,500 surveyed adults acknowledge vaccination benefits, 63.9% do not know the vaccines in the National Vaccination Programme and 90.5% are unaware of vaccines outside it.
Over 75% of participants would accept vaccines if recommended by family doctors, yet 38.8% skip seasonal shots due to low perceived risk and 50.0% do not view them as a personal priority.
In an analysis of 15,000 admissions at ULS EDV between 2018 and 2024, Dr. Gonçalo Sarmento found 345 adult RSV cases, with over 90% aged above 60 and an in-hospital death rate of 18.3%.
The adult RSV vaccine costs roughly 200 euros out of pocket, prompting calls from physicians and Respira president José Albino for National Health Service co-funding for vulnerable seniors.
Widespread support paired with low awareness
A nationwide survey of 1,500 Portuguese adults conducted between 28 May and 4 August 2026 revealed that while 94.4% of respondents recognize the benefits of vaccination, widespread informational deficits persist across the adult population. According to the study promoted by the Movement of Patients for Vaccination (MOVA), 63.9% of participants do not know which vaccines are included in the National Vaccination Programme (PNV). Furthermore, 90.5% are unaware of adult vaccines that exist outside the public programme, and 62.1% cannot identify any specific vaccines they would like added in the future.
- Recognize vaccine benefits
- 94.4 %
- Unaware of vaccines outside PNV
- 90.5 %
- Never heard of vaccine fatigue or hesitation
- 74.9 %
- Unaware of vaccines in PNV
- 63.9 %
- Unaware of recommendations for age or condition
- 50.2 %
- Do not view seasonal shots as personal priority
- 50 %
- Skip seasonal shots due to low perceived risk
- 38.8 %
Data from the article text
Communication gaps in clinical consultations
General practitioners remain the primary catalyst for adult immunization, with over 75% of respondents indicating they would get vaccinated if their family doctor recommended it. However, participants reported that vaccination is rarely addressed during routine medical appointments, particularly for individuals without chronic illnesses. Among people who skip annual influenza or Covid-19 shots, 38.8% stated they do not feel at risk, while 50.0% do not consider seasonal immunization a personal priority. Furthermore, 74.9% of respondents had never heard of the terms vaccine hesitation or vaccine fatigue. José Albino, president of Respira and representative of MOVA, pointed out that lack of awareness prevents informed choices.
“Vaccination is an act of individual and collective protection and people know that, as the data shows. But it is not possible to ask them to protect themselves, and protect those around them, through vaccination, when they lack basic knowledge about what vaccines are available.”
- Unaware of PNV vaccines (without chronic disease)
- 76.4 %
- Unaware of PNV vaccines (all adults)
- 63.9 %
- Seasonal vaccine not a priority (healthy adults)
- 67.5 %
- Seasonal vaccine not a priority (all adults)
- 50 %
- Unaware of recommendations (all adults)
- 50.2 %
- Unaware of recommendations (with chronic disease)
- 41 %
Data from the article text
Severe RSV hospital outcomes in older adults
Hospital data from Santa Maria da Feira illustrates the clinical risks of unaddressed adult respiratory infections. An investigation led by internal medicine specialist Gonçalo Sarmento analysed 15,000 patients admitted for acute respiratory infections at the Unidade Local de Saúde do Entre Douro e Vouga (ULS EDV) between 2018 and 2024. The study identified Respiratory Syncytial Virus (RSV) in 345 hospitalized adults. Among those diagnosed with RSV, more than 90% were over 60 years old and nearly 80% belonged to high-risk groups with chronic illnesses. More than half of the 345 patients developed acute respiratory failure, and 18.3% died during their hospital stay. Sarmento presents these findings on Thursday in Coimbra.
Calls for state subsidy and clinical action
While infant RSV immunization is fully integrated into the PNV free of charge, the adult vaccine requires out-of-pocket payment of approximately 200 euros despite demonstrated efficacy lasting at least three years. Sarmento argued that the National Health Service (SNS) should co-fund the vaccine for older adults to prevent acute respiratory failure, irreversible lung sequelae, and cardiovascular events triggered by infection.
“Not every senior has money for that. But if the SNS starts co-funding the vaccine, it will be a decisive step to guarantee greater longevity for our senior population, who, when infected by this virus, are subject to acute respiratory failure, lung injuries that can leave sequelae, and inflammation that increases the likelihood of chronic disease decompensating or even leading to heart attacks or strokes.”
Public health authorities also acknowledged the urgency of targeting vulnerable demographics, with Cristina Bárbara of the Directorate-General of Health (DGS) emphasizing the responsibility to protect high-risk groups.
“We have to protect the most vulnerable populations.”
Ask about this text
Sources and context
- SIC NotíciasEstudo revela que a maioria dos portugueses desconhece as vacinas recomendadas
- Notícias ao MinutoEstudo a 15.000 doentes propõe vacina contra vírus sincicial
- Diário de NotíciasMaioria reconhece importância da vacinação mas desconhece vacinas recomendadas
- ObservadorMaioria reconhece importância da vacinação mas desconhece vacinas recomendadas
- José Albino
- President of respiratory patients association Respira and representative of MOVA
- Places
- Santa Maria da Feira, Portugal, Coimbra, Lisbon
Pollar is free and carries no ads in the text. Its members keep it going.
Support Pollar